Acute Coronary Syndromes (ACS)

heartwire News

  • AHA/ACC Issue New Performance, Quality Measures for MI The updated set includes seven new quality measures for in-house quality improvement and four new performance measures for public reporting or pay-for-performance programs.
  • Cardiac Risk the Same With All Sulfonylureas in Diabetes There is no difference in cardiac risk between nonspecific, long-acting sulfonylureas and specific, short-acting agents, although the former are more likely to provoke severe hypoglycemia.
  • ESC Data Bolster Dual Antithrombotic Therapy in AF PCI Patients A new study supports forgoing traditional triple antithrombotic therapy with aspirin for dual therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation who've undergone PCI.
  • EASD Aortic Aneurysm Risk Is Smaller in Type 2 Diabetes Patients "While it's good that people with diabetes may get less" aortic aneurysm, they still need to lower blood pressure, control lipids, and stop smoking to prevent overall cardiovascular risk, an expert noted.

Perspective

  • ESC 2017: Updates in Antithrombotic Strategies   Drs Jolly and Granger discuss three trials presented at ESC 2017 that are making waves in thrombocardiology.
  • Painless Aortic Dissection in the Emergency Department Real-life AAD may not resemble the textbook description, so always consider AAD in sick patients even in the absence of chest pain, says Dr Mattu.
  • CANTOS: Future Promise for Targeting Inflammation in CVD   Modulating the inflammatory cascade was beneficial in the secondary prevention of cardiovascular disease with some surprising off-target effects. Drs Yancy and Byrne review the implications of CANTOS.
  • ESC Women and Heart Disease: A Different Animal Dr Melissa Walton-Shirley recounts a presentation by Dr Noel Bairey Merz on clinics dedicated to women and MI without obstructive coronary artery disease, heart failure with preserved ejection fraction, and adverse pregnancy outcomes.